ID

34205

Beskrivning

A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01326000

Länk

https://clinicaltrials.gov/show/NCT01326000

Nyckelord

  1. 2019-01-15 2019-01-15 -
  2. 2019-05-14 2019-05-14 -
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

15 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Colorectal Cancer NCT01326000

Eligibility Colorectal Cancer NCT01326000

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/= 18 years of age
Beskrivning

ID.1

Datatyp

boolean

carcinoma of the colon and/or rectum
Beskrivning

ID.2

Datatyp

boolean

disease progression during or within 6 months of last dose of oxaliplatin containing first-line combination therapy for metastatic disease
Beskrivning

ID.3

Datatyp

boolean

ecog performance status 0-1
Beskrivning

ID.4

Datatyp

boolean

adequate hematological, renal and liver function
Beskrivning

ID.5

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with monoclonal antibody/small molecule against epidermal growth factor receptor (egfr)
Beskrivning

ID.6

Datatyp

boolean

prior treatment with irinotecan
Beskrivning

ID.7

Datatyp

boolean

radiotherapy within the last 4 weeks before first dose of study drug (except for limited field palliative radiotherapy for bone pain relief)
Beskrivning

ID.8

Datatyp

boolean

cns metastasis
Beskrivning

ID.9

Datatyp

boolean

history of or active autoimmune disorders/conditions
Beskrivning

ID.10

Datatyp

boolean

Similar models

Eligibility Colorectal Cancer NCT01326000

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
adult patients, >/= 18 years of age
boolean
ID.2
Item
carcinoma of the colon and/or rectum
boolean
ID.3
Item
disease progression during or within 6 months of last dose of oxaliplatin containing first-line combination therapy for metastatic disease
boolean
ID.4
Item
ecog performance status 0-1
boolean
ID.5
Item
adequate hematological, renal and liver function
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
prior treatment with monoclonal antibody/small molecule against epidermal growth factor receptor (egfr)
boolean
ID.7
Item
prior treatment with irinotecan
boolean
ID.8
Item
radiotherapy within the last 4 weeks before first dose of study drug (except for limited field palliative radiotherapy for bone pain relief)
boolean
ID.9
Item
cns metastasis
boolean
ID.10
Item
history of or active autoimmune disorders/conditions
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial